Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.42 |
| ▸ | TACR3 | P29371 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 4/20 | 0.40 |
| ▸ | PGR | P06401 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7656122 | 0.96 | HRH1 (0.43) | HRH1HRH3SIGMAR1TACR3CNR1 | |
| SCHEMBL7652519 | 0.84 | ADRA1A (0.40) | HRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7657286 | 0.83 | HRH1 (0.51) | HRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7659345 | 0.81 | HRH1 (0.44) | HRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7675326 | 0.72 | HRH1 (0.47) | HRH1HRH3SIGMAR1 | |
| SCHEMBL7660411 | 0.72 | HRH1 (0.53) | HRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7659680 | 0.71 | POLB (0.46) | TACR3PGR | |
| SCHEMBL7748894 | 0.71 | ADRA1D (0.55) | TACR3 | |
| SCHEMBL7749030 | 0.70 | DRD2 (0.55) | — | |
| SCHEMBL7657825 | 0.70 | CCR2 (0.50) | HRH1HRH3SIGMAR1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436962-B1 | ALPHA 1A ADRENERGIC RECEPTOR ANTAGONISTS; RELIEF FROM BENIGN PROSTATIC HYPERPLASIA BY LESS HINDERED URINE FLOW BY RELAXING SMOOTH MUSCLE TISSUE; WITH A TESTOSTERONE 5-ALPHA REDUCTASE INHIBITOR, FINASTERIDE; ACUTE AND CHRONIC RELIEF | MERCK & CO., INC. | 2002-08-20 | — | — | US | disclosed |